Список проголосовавших за комментарий " Sector Summary: The Healthcare sector (+0.33%) is trading higher today, outperforming the S&P 500 (+0.15%)<strong><span style="color:#228822;">Gainers on news:</span></strong><br/> <ul><li>CytomX Therapeutics (<strong>CTMX</strong> +11.19%) files for approx 10.9 mln share common stock offering by selling shareholders</li><li>Prothena (<strong>PRTA</strong> +6.79%) will present results from its Phase 1b Multiple Ascending Dose Study of PRX002/RG7935 in Patients with Parkinson's Disease in an webcast on April 2, 2017 at 9:00 AM ET</li><li>IsoRay (<strong>ISR</strong> +1.96%) announces that the previously announced Stipulation of Settlement has been approved by the U.S. District Court for the Eastern District of Washington</li></ul><strong><span style="color:#ff0000;">Decliners on news:</span></strong><br/> <ul><li>Radius Health (<strong>RDUS</strong> -10.84%) receives FDA notification of PDUFA extension for Abaloparatide-SC until June 30, 2017</li><li>Argos Therapeutics (<strong>ARGS</strong> -10%) approves workforce action plan designed to streamline operations and reduce the Company's operating expenses</li><li>BioCryst Pharma (<strong>BCRX</strong> -1.72%) prices offering of 5,294,118 shares of its common stock at $8.50 per share</li></ul><strong><span style="color:#228822;">Gainers on earnings:</span></strong><br/> <ul><li>Tetraphase Pharma (<strong>TTPH</strong> +16.45%) misses by $0.01, misses on revs</li><li>Zafgen (<strong>ZFGN</strong> +15.44%) beats by $0.12, reports no revenue</li><li>Providence Service Corp (<strong>PRSC</strong> +11.9%) misses by $0.12, misses on revs</li></ul><strong><span style="color:#ff0000;">Decliners on earnings:</span></strong><br/> <ul><li>Ocera Therapeutics (<strong>OCRX</strong> -21.22%) reports Q4 EPS of ($0.22) vs ($0.33) Capital IQ Consensus; revs 512K versus 24K last year.</li><li>TearLab (<strong>TEAR</strong> -17.2%) beats by $0.09, misses on revs; to explore strategic alternatives</li><li>Second Sight Medical Products (<strong>EYES</strong> -10.32%) misses by $0.07, misses on revs</li></ul><strong>Upgrades/Downgrades:</strong><br/> <ul><li>LHC Group (<strong>LHCG</strong> +5.75%) RBC Capital Mkts Upgraded to OUTPERFORM (from Sector Perform) — Price Target: 58 (from 44)</li><li>Sierra Oncology (<strong>SRRA</strong> +5.24%) upgraded to Buy from Hold at SunTrust</li><li>AbbVie (<strong>ABBV</strong> +2.56%) added to Conviction Buy List at Goldman</li><li>Ionis Pharma (<strong>IONS</strong> -11.88%) downgraded to Sell from Neutral at Goldman</li><li>Surgery Partners (<strong>SGRY</strong> -8.23%) downgraded to Hold at Stifel; tgt raised to $19</li></ul>"